about
Association of common variants in the human eyes shut ortholog (EYS) with statin-induced myopathy: evidence for additional functions of EYSA nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial diseaseThe muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicityThe Interaction Between Statins and Exercise: Mechanisms and Strategies to Counter the Musculoskeletal Side Effects of This Combination TherapyStatin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and ManagementCoenzyme Q10 and Neurological Diseases.Effect of Coenzyme Q10 and green tea on plasma and liver lipids, platelet aggregation, TBARS production and erythrocyte Na leak in simvastatin treated hypercholesterolmic rats.Considerations for supplementing with coenzyme Q10 during statin therapy.Evidence for metabolic aberrations in asymptomatic persons with type 2 diabetes after initiation of simvastatin therapyCoQ10 deficiency diseases in adults.Treatment Options for Statin-Associated Muscle Symptoms.Effect of coenzyme Q10 and Ardisia japonica Blume on plasma and liver lipids, platelet aggregation, and erythrocyte Na efflux channels in simvastatin-treated guinea pigs.Coenzyme Q10: is there a clinical role and a case for measurement?Molecular mechanisms of statin intoleranceEffect of rosuvastatin on plasma coenzyme Q10 in HIV-infected individuals on antiretroviral therapy.Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS)Molecular basis for statin-induced muscle toxicity: implications and possibilities.Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect.Intolerance to statins: mechanisms and management.Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations.Coenzyme q10 and statin-induced mitochondrial dysfunction.Update on toxic myopathies.Drugs and mitochondrial diseases: 40 queries and answers.Targeting tumor cell metabolism with statins.Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.The role of mitochondria in statin-induced myopathy.Inflammatory myopathy associated with statins: report of three cases.The Combination of Physical Exercise with Muscle-Directed Antioxidants to Counteract Sarcopenia: A Biomedical Rationale for Pleiotropic Treatment with Creatine and Coenzyme Q10.A common missense variant of LILRB5 is associated with statin intolerance and myalgia.Red yeast rice and coenzyme Q10 as safe alternatives to surmount atorvastatin-induced myopathy in hyperlipidemic rats.Drug-Induced Mitochondrial Toxicity.Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update.Statin-associated changes in skeletal muscle function and stress response after novel or accustomed exercise.
P2860
Q24320093-2EA7886C-E1F2-4E70-B065-DC3931B7E686Q24645475-D45C0CA1-788B-4338-9811-D174155FEE8CQ24681859-2D8629AF-2DF4-4A7B-83AC-D23FA20C0344Q26771168-9BB1617B-7485-49C8-A17B-5EEFF8367245Q28083004-DBB81949-A7AC-40DE-AA1E-288E4C7CA578Q30440307-9E7DA56D-715F-42B6-9277-E368E16839AEQ33767583-9AABBA0B-E414-4936-AA10-55C183294903Q34564606-6C7735E7-2E22-4938-BFF3-B1B9B3711C7FQ35875974-2096FCAE-D70A-45AA-B336-D9BE6328B05AQ36026895-CA62A0FC-8C91-4566-A55F-69C9776FE3A4Q36294394-55EB37A0-57E0-4FC8-90B3-F6E29067D813Q36424619-D0496109-EF03-42FA-9888-FBE5A08CF7EBQ36869671-4C7DBA6E-169D-4ACB-9103-9B9C9F06E931Q36958324-D0B3B5C4-BEC0-4996-BDE9-81957FA58C84Q37165704-9E96FB07-928A-4F92-8D7D-8678E7F12147Q37192985-8F40D576-53BA-466F-AED3-4978740837C8Q37235648-E3BED140-9E2F-41F2-9314-D7A86E2B753CQ37326940-504779E5-4142-4720-8D2D-A7106FCB8661Q37577161-A0DD9C52-B967-4BF2-A45F-9032AEA6A9C8Q37724200-B2DEC69F-87A2-4614-941F-E6E1714DD5D6Q37878308-29E96C0D-6699-4F11-B6EE-402CAAA1B51CQ37942033-F78DDDF3-6E61-42BD-A7EC-65CBF74AD4BAQ37980195-87DC1961-2176-46DA-A675-E7280C7FD0A3Q37981833-6CC5019E-0921-4268-932A-AA36220ADE44Q38114007-107A6284-EA69-49F5-BD78-E3F38CF43002Q38492567-31C18F36-9A31-4C48-BB68-79DF8B8086C9Q42706490-F1F5B701-CB65-473B-AADE-2115454852BCQ45833603-E9E88062-5598-48F1-B7C6-673A15AAF3D7Q47747535-E090EF5F-A02F-4CD3-AE9E-EEE98FCB177BQ50469720-EFD877FA-7FA8-4A4B-B913-3374D3DD04B7Q51538858-40839856-22CF-4CD4-91B5-9592AB27B39CQ51761248-378F288F-1832-41B7-8701-928C15927D06Q54548515-0FB26B8A-2D29-457E-BD5B-661FCDA0AD8E
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Muscle coenzyme Q10 level in statin-related myopathy.
@ast
Muscle coenzyme Q10 level in statin-related myopathy.
@en
type
label
Muscle coenzyme Q10 level in statin-related myopathy.
@ast
Muscle coenzyme Q10 level in statin-related myopathy.
@en
prefLabel
Muscle coenzyme Q10 level in statin-related myopathy.
@ast
Muscle coenzyme Q10 level in statin-related myopathy.
@en
P2093
P50
P1433
P1476
Muscle coenzyme Q10 level in statin-related myopathy.
@en
P2093
Alessandro Prelle
Ali B Naini
Petra Kaufmann
Valeria Lucchini
P304
P356
10.1001/ARCHNEUR.62.11.1709
P577
2005-11-01T00:00:00Z